Involvement of the vanilloid receptor 1 in the mechanism of analgetic effect of ketorolac

[1] Akerman S, Kaube H, Goadsby PJ. Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol. 2004;142(8): 1354-1360.10.1038/sj.bjp.0705896Search in Google Scholar

[2] Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther. 2006; 79(1):9-19.10.1016/j.clpt.2005.09.009Search in Google Scholar

[3] Diaz-Reval MI, Ventura-Martinez R, Dйciga-Campos M, et al. Evidence for a central mechanism of action of S-(+)- ketoprofen. Eur J Pharmacol. 2004;483(2-3):241-248.10.1016/j.ejphar.2003.10.036Search in Google Scholar

[4] Gibbons JD, Chakraborti S. Nonparametric statistical inference. Boca Raton: CRC Press; 2011.10.1201/9781439896129Search in Google Scholar

[5] Hцgestдtt ED, Jцnsson BAG, Ermund A. Conversion of Acetaminophen to the Bioactive N-Acylphenolamine AM404 via Fatty Acid Amide Hydrolase-dependent Arachidonic Acid Conjugation in the Nervous System. J Biol Chem. 2005; 280(36): 31405-31412.10.1074/jbc.M501489200Search in Google Scholar

[6] Komlos E, Porsresr J. Morfin - prostigmin synergismus. Az Acta Phisiologica Acad Scient Hungaricae. 1950;1: 77-83.Search in Google Scholar

[7] Metzler DE, Metzler CM. Biochemistry: The chemical reactions of living cells, San Diego, CA [etc.]: Harcourt/Academic Press; 2001.Search in Google Scholar

[8] Masubuchi Y, Ose A, Horie T. Diclofenac-induced inactivation of CYP3A4 and its stimulation by quinidine. Drug Metab and Disp. 2002;30(10):1143-1187.10.1124/dmd.30.10.1143Search in Google Scholar

[9] Mroszczak EJ, Lee FW, Combs D. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.Drug Metab Dispos. 1987;15:618-626.Search in Google Scholar

[10] Pegram BL. The portal vein is a model for resistance vassels.In: Pegram BL. Vascular Neuroeffector Mechanisms.New-York: Raven Press; 1980.Search in Google Scholar

[11] Premkumar LS, Sikand P. TRPV1: A Target for next generation Analgesics. Curr Neuropharmacol. 2008;6(2):151-163.10.2174/157015908784533888Search in Google Scholar

[12] Roberts LJ, Marrow JD. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of Gout. In: Hardman J.G., Limbird L.E. Goodman & Gilman’s The Pharmacological Basis of Therapeutics 10th Edition. McGraw Hill; 2001.Search in Google Scholar

[13] Scotland RS, Chauhan S, Davis C et al. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation.Circ Res. 2004;95:1027-1034.10.1161/01.RES.0000148633.93110.24Search in Google Scholar

[14] Suh YG, Oh U. Activation and activators of TRPV1 and their pharmaceutical implication. Curr Pharm Des. 2005(11):2687-2698.10.2174/1381612054546789Search in Google Scholar

[15] The engineer’s ultimate guide to wavelet analysis. The wavelet tutorial (http://users.rowan.edu/~polikar/wavelets/wttutorial.html). Revised January 2011. Accessed September 15, 2011.Search in Google Scholar

[16] Urban L, Dray A. Capsazepine, a novel capsaicin antagonist, selectively antagonises the effects of capsaicin in the mouse spinal cord in vitro. Neurosci Lett. 1991;134:9-11.10.1016/0304-3940(91)90496-GSearch in Google Scholar

[17] Varrassi G., Marinangel F, Agro F et al. A double-blinded evaluation of propacetamol versus ketorolac in combination with patient-controlled analgesia morphine: analgesic efficacy and tolerability after gynecologic surgery.Anesth Analg. 1999;88:611. 10.1213/00000539-199903000-00028Search in Google Scholar